NDA submitted for adefovir.
D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D002331:Carnitine / Q000008:administration & dosage; D017277:Drug Approval; D004349:Drug Packaging; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage*; D014481:United States; D014486:United States Food and Drug Administration
D063065:Organophosphonates; D018894:Reverse Transcriptase Inhibitors; D000225:Adenine; D002331:Carnitine; C106812:adefovir dipivoxil